Standard protocols for chimpanzee IL-13 expression typically involve:
Expression systems:
Purification:
IL-13 mediates immune responses through:
Receptor binding:
Downstream effects:
Chimpanzee IL-13 enables species-specific investigations of:
Allergic inflammation: Mediates IgE class switching and eosinophil recruitment
Fibrotic pathways: Induces TGF-β1 production in epithelial cells
Parasitic immunity: Regulates schistosomiasis defense mechanisms
Table 2: Key bioassay parameters
Human and chimpanzee IL-13 demonstrate functional overlap:
Pan troglodytes (chimpanzee) IL13 is a protein-coding cytokine that functions as an immunoregulatory molecule. It is encoded by the IL13 gene (Entrez Gene ID: 449564) in chimpanzees . Like its human counterpart, chimpanzee IL13 plays critical roles in inhibiting inflammatory cytokine production and regulating inflammatory and immune responses . The two proteins share high sequence homology, reflecting their evolutionary relationship, though researchers should note specific amino acid differences that may impact certain experimental applications when working across species.
Pan troglodytes IL13 contains functional domains similar to those identified in human IL13. The protein features binding sites for interaction with its receptors (IL13RA1, IL13RA2, and IL4R) . These domains are critical for its biological functions, including synergizing with IL2 in regulating interferon-gamma synthesis and positively regulating IL31RA expression in macrophages . When designing experiments targeting specific domains, researchers should consider the conserved nature of these functional regions across primates.
Based on comparative analysis with human IL13, recombinant Pan troglodytes IL13 is expected to be a monomeric protein with a molecular mass of approximately 12-13 kDa . The predicted structure includes multiple alpha-helical regions that contribute to its tertiary configuration. When visualized via SDS-PAGE, reduced protein typically migrates at approximately 9 kDa, while non-reduced protein migrates at approximately 8 kDa, similar to other mammalian IL13 proteins .
Based on established protocols for mammalian IL13 production, E. coli expression systems are commonly used for recombinant Pan troglodytes IL13 production . When designing expression constructs, researchers should:
Include a signal sequence for proper secretion
Consider codon optimization for E. coli expression
Incorporate a purification tag that minimally interferes with protein function
Ensure proper disulfide bond formation through appropriate oxidative folding conditions
For applications requiring post-translational modifications, mammalian expression systems may be preferable, though yields are typically lower than bacterial systems.
For optimal stability and activity retention, recombinant Pan troglodytes IL13 should be:
Reconstituted in sterile 10 mM HCl at a concentration of 0.1 mg/mL (based on protocols for human IL13)
Gently mixed without vortexing to prevent protein denaturation
For long-term storage, diluted to working aliquots in a 0.1% BSA solution
Stored at -80°C to minimize degradation
Freeze-thaw cycles should be avoided to prevent activity loss
Proper reconstitution is critical for maintaining biological activity, particularly for functional assays measuring cytokine responses.
To ensure experimental reproducibility, researchers should validate recombinant Pan troglodytes IL13 through multiple quality control assessments:
| Quality Control Parameter | Method | Acceptance Criteria |
|---|---|---|
| Purity | Reducing and Non-Reducing SDS-PAGE | ≥95% |
| Endotoxin Content | Kinetic LAL Assay | ≤1 EU/μg |
| Biological Activity | TF-1 Cell Proliferation Assay | ED50 ≤5 ng/mL |
| Identity | Mass Spectrometry | Matches theoretical mass |
| Structure | Circular Dichroism | Appropriate secondary structure |
Additionally, N-terminal sequencing can confirm the absence of unexpected modifications that might affect function .
Pan troglodytes IL13 mediates its effects through interaction with a complex receptor system composed of IL4Rα and two IL13 binding proteins (IL13Rα1 and IL13Rα2) . This interaction initiates signaling primarily through the JAK/STAT pathway, particularly STAT6 . The IL13Rα2 component has been demonstrated to function as a high-affinity decoy receptor, potentially serving to regulate IL13 activity in tissues . In experimental designs, researchers should consider using receptor blocking antibodies to dissect specific signaling pathways activated by Pan troglodytes IL13.
Several functional assays can effectively measure Pan troglodytes IL13 bioactivity:
TF-1 cell proliferation assays, which measure dose-dependent growth responses
Phospho-STAT6 detection in responsive cells using flow cytometry or Western blotting
Quantification of IL13-induced gene expression changes by qRT-PCR
Assessment of IgE production in B cells following IL13 stimulation
Measurement of IL13-dependent inhibition of inflammatory cytokine production (IL-1β, TNF-α, IL-8, IL-6)
When designing these assays, include appropriate positive controls and generate full dose-response curves to accurately determine EC50 values.
Pan troglodytes IL13, like its human counterpart, likely plays a crucial role in type 2 immune responses. It functions as an immunoregulatory cytokine predominantly secreted by activated Th2 cells and is implicated in allergic inflammation pathogenesis . In research contexts, Pan troglodytes IL13 can be used to study:
Regulation of inflammatory responses in primate-derived cell systems
Comparison of evolutionary conserved immune pathways across species
Modulation of IgE production in B cells
Inhibition of inflammatory cytokine production
Regulation of epithelial cell regeneration, particularly in gastrointestinal contexts
The protein's ability to synergize with IL2 in regulating interferon-gamma synthesis highlights its complex role in immune response coordination .
The evolutionary conservation and subtle differences between human and Pan troglodytes IL13 provide valuable research opportunities:
Structure-function analysis to identify species-specific activity determinants
Investigation of differential receptor binding affinity and signaling outcomes
Comparative genomics to understand evolutionary selection pressures on IL13
Development of cross-reactive therapeutic antibodies with broader applications
Study of species-specific immune response regulation in comparative immunology
When conducting such studies, researchers should precisely document species-specific amino acid differences and correlate them with functional outcomes to advance understanding of cytokine evolution.
For investigating tissue-specific effects of Pan troglodytes IL13, researchers can employ:
Organoid cultures derived from chimpanzee tissues to study IL13 responses in a controlled environment
Receptor expression profiling across tissues to identify potential responsive cell populations
Chimeric receptor systems to delineate species-specific signaling components
Conditional expression systems in model organisms to study tissue-restricted IL13 activity
Analysis of IL13-dependent gene expression changes in different tissue contexts
The role of IL13Rα2 in epithelial cell regeneration in the gastrointestinal tract suggests important tissue-specific functions that warrant detailed investigation .
Advanced genetic approaches for studying Pan troglodytes IL13 include:
CRISPR/Cas9-mediated gene editing in chimpanzee cell lines to create IL13 or receptor knockouts
Generation of reporter constructs containing chimpanzee IL13 promoter regions to study transcriptional regulation
Single-cell RNA sequencing to identify IL13-responsive cell populations
Chromatin immunoprecipitation to map transcription factor binding at the IL13 locus
Analysis of epigenetic modifications regulating IL13 expression in different immune contexts
These approaches can reveal nuanced aspects of IL13 biology specific to Pan troglodytes that may inform broader understanding of cytokine evolution and function.
Researchers may encounter several challenges when working with recombinant Pan troglodytes IL13:
Low activity after reconstitution: Ensure proper reconstitution in acidic buffer (10 mM HCl), avoid vortexing, and use non-binding tubes for dilution
Aggregation during storage: Add carrier protein (0.1% BSA) to working solutions and store in small aliquots to prevent freeze-thaw cycles
Cross-reactivity in immunoassays: Validate antibody specificity against both human and chimpanzee IL13 to ensure reliable detection
Variable potency between lots: Perform lot-specific bioassays and standardize to international cytokine standards when available
Endotoxin contamination: Use endotoxin-free reagents during purification and perform LAL testing to ensure levels ≤1 EU/μg
To distinguish IL13-specific effects from those of related cytokines (particularly IL4):
Use IL13-specific neutralizing antibodies in parallel with broad cytokine inhibitors
Compare responses in wild-type cells with those in IL13Rα2-deficient systems
Employ receptor-specific blocking antibodies to differentiate IL13Rα1 versus IL4Rα-mediated effects
Conduct comparative studies with recombinant IL4 and IL13 across concentration ranges
Utilize IL4Rα-deficient systems to isolate IL13-specific signaling through IL13Rα2
The overlapping yet distinct functions of IL13 and IL4 necessitate careful experimental design to parse cytokine-specific effects.
When designing comparative studies of IL13 across primate species, researchers should:
Account for potential differences in receptor binding affinity that may require species-adjusted dosing
Consider using both species-matched and cross-species receptor-expressing cell systems
Include appropriate positive controls for each species-specific system
Normalize activity to international standards when comparing potency
Sequence-verify all recombinant proteins to document species-specific variations
The importance of IL13 in immune regulation makes it a valuable target for evolutionary immunology studies, but careful experimental design is essential for valid cross-species comparisons.